{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:57Z","timestamp":1791308877628,"version":"4.3.1"},"reference-count":55,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Candida glabrata<\/jats:italic>\n                    is a pathogenic yeast with several unique biological features. This article provides an up\u2010to\u2010date review on current data and reasoning aspects of this clinically problematic organism. Haploidy, absence of pseudohyphae, facultative anaerobe growth of\n                    <jats:italic>C.\u00a0glabrata<\/jats:italic>\n                    , as well as its intrinsically low susceptibility to azole antifungals require specific consideration in diagnosis and treatment approaches. As\n                    <jats:italic>C.\u00a0glabrata<\/jats:italic>\n                    today represents a sizeable percentage of pathogens in candidaemia, the use of azole antifungals in upfront therapy of invasive yeast infections is discouraged by recent guidelines. While the selection of\n                    <jats:italic>C.\u00a0glabrata<\/jats:italic>\n                    mutants with impaired susceptibility to echinocandins has been described, analyses of several clinical studies indicate an association of improved outcomes with the use of echinocandins as the primary treatment for invasive yeast infections with potential or documented involvement of\n                    <jats:italic>C.\u00a0glabrata<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1111\/myc.12348","type":"journal-article","created":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T11:45:04Z","timestamp":1437824704000},"page":"445-450","source":"Crossref","is-referenced-by-count":49,"title":["<i>Candida glabrata \u2013<\/i>\n                    unique features and challenges in the clinical management of invasive infections"],"prefix":"10.1111","volume":"58","author":[{"given":"A.","family":"Gl\u00f6ckner","sequence":"first","affiliation":[{"name":"BDH\u2010Klinik Greifswald GmbH Greifswald Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Cornely","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine Cologne Excellence Cluster on Cellular Stress Responses in Aging\u2010Associated Diseases (CECAD) Clinical Trials Centre Cologne (ZKS K\u00f6ln, BMBF 01KN1106) Center for Integrated Oncology (CIO K\u00f6ln Bonn) German Centre for Infection Research (DZIF) University of Cologne Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2005.06.012"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-623"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-014-9800-2"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02116-07"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444911054898"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2013.767323"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-2009-3"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00062-14"},{"key":"e_1_2_8_10_1","first-page":"424","article-title":"Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005","volume":"2007","author":"Borg\u2010von Zepelin M","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3408-3"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-014-9786-9"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.09.005"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/599039"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00029-06"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb02718.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345990780040601"},{"key":"e_1_2_8_18_1","unstructured":"Gl\u00f6cknerA AbelP BernhardtH ZimmermanK WiersbitzkyMet\u00a0al.Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Poster M\u2010874.San Diego 2002."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1086\/513663"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181cc4734"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2011.02069.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01198-14"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt285"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47842-0"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-014-9772-2"},{"key":"e_1_2_8_26_1","unstructured":"European Committee on Antimicrobial Susceptibilty Testing.Antifungal clinical breakpoint table v. 7.0 2014\u201008\u201012[WWW document]. URLwww.eucast.org[accessed on April 17 2015]."},{"key":"e_1_2_8_27_1","first-page":"2846","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, to 2012","volume":"2012","author":"Pfaller MA","year":"2010","journal-title":"J Clin Microbiol"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/502104"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/423274"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2011.23.5.310"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00296-07"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00474-06"},{"key":"e_1_2_8_33_1","unstructured":"2013 Update of the ECIL guidelines for antifungal therapy in leukemia and HCST patients (ECIL\u20105). European Conference on Infections in Leukemia [WWW document]. URLwww.kobe.fr\/ecil\/telechargements2013\/ECIL5%20Antifungal%20Therapy.pdf[accessed on April 17 2015]."},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12039"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/596757"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit136"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu407"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01144-13"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02189-13"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03593-13"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06112-11"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2011.02044.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2000.0918"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066906"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021585"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60605-9"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1086\/520980"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67490-9"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066906"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis021"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00179-11"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks482"},{"key":"e_1_2_8_53_1","unstructured":"KullbergBJ ConteU SchlammHet\u00a0al.Efficacy of anidulafungin in 504 patients with invasive candidiasis from a pooled clinical trial database. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Poster M\u20101229.San Francisco 2012."},{"key":"e_1_2_8_54_1","unstructured":"HerbrechtR ConteU BiswasP CapparellaMR AramJ.Efficacy and safety of anidulafungin in the treatment of invasive candidiasis in neutropenic patients: analysis of pooled data from five prospective studies. Poster P1187.Milan:Congress of the European Hematology Association 2014."},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03784.x"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00863-13"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fmyc.12348","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/myc.12348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T16:36:05Z","timestamp":1696264565000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/myc.12348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/myc.12348"],"URL":"https:\/\/doi.org\/10.1111\/myc.12348","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}